Affordable Access

Publisher Website

Recent developmentsin respiratory care pharmacology

Authors
Journal
Journal of PeriAnesthesia Nursing
1089-9472
Publisher
Elsevier
Publication Date
Volume
13
Issue
6
Identifiers
DOI: 10.1016/s1089-9472(98)80007-5

Abstract

Bronchoactive inhaled aerosol drugs target the respiratory tract directly andseek to minimize systemic exposure and reduce side effects. Common delivery devices such as the metered dose inhaler, the small volume nebulizer, or the dry powder inhaler each deliver approximately the same fraction of dose (10%) to the lungs, although their dose amounts are not equivalent. Major respiratory drug groups are reviewed, and include the β-adrenergic and anticholinergic bronchodilators, mucolytic agents, corticosteroids, mediator antagonists, anti-infective agents, and exogenous surfactants. New agents in each group are identified and briefly described, along with the clinical use and most commonly observed side effects for each class of drugs.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments